This inventor holds 2 USPTO granted patents. Top assignees: Bioventures, LLC, University of Arkansas. Active years: 2010-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2020
Title: The Innovations of Eric C. Peterson
Introduction
Eric C. Peterson is an accomplished inventor based in Little Rock, Arkansas. He has made significant contributions to the field of drug treatment through his innovative patents. With a total of 2 patents, Peterson's work focuses on addressing drug abuse and addiction.
Latest Patents
Peterson's latest patents include groundbreaking inventions aimed at combating drug addiction. One of his notable inventions is an antibody-nanoparticle conjugate designed for the treatment of drug abuse. This invention relates to an antibody composition that includes antibodies conjugated to nanoparticles, which can be utilized in methods to treat drug use and its effects. Another significant patent involves monoclonal antibodies that selectively recognize methamphetamine and similar compounds. This invention is particularly important as it targets compounds like (+) methamphetamine, (+) amphetamine, and (+) MDMA, while not recognizing their negative counterparts.
Career Highlights
Throughout his career, Eric C. Peterson has worked with esteemed organizations such as the University of Arkansas and Bioventures, LLC. His work in these institutions has allowed him to further his research and develop innovative solutions to pressing issues related to drug addiction.
Collaborations
Peterson has collaborated with notable colleagues, including S. Michael Owens and Melinda Gunnell. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Eric C. Peterson's contributions to the field of drug treatment through his innovative patents highlight his dedication to addressing critical health issues. His work continues to pave the way for advancements in the treatment of drug addiction.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

